Page last updated: 2024-08-22

pyrvinium and Astrocytoma, Grade IV

pyrvinium has been researched along with Astrocytoma, Grade IV in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bakhshinyan, D; Bhatia, M; Doble, BW; Garg, N; Hallett, R; Hassell, JA; Lach, B; Mahendram, S; Manoranjan, B; McFarlane, N; Murty, NK; Nolte, SM; Provias, JP; Qazi, MA; Reddy, K; Singh, M; Singh, SK; Subapanditha, M; Venugopal, C; Vijayakumar, T; Vora, P1

Other Studies

1 other study(ies) available for pyrvinium and Astrocytoma, Grade IV

ArticleYear
Pyrvinium Targets CD133 in Human Glioblastoma Brain Tumor-Initiating Cells.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2015, Dec-01, Volume: 21, Issue:23

    Topics: AC133 Antigen; Animals; Antigens, CD; Antineoplastic Agents; Brain Neoplasms; Cell Proliferation; Cell Self Renewal; Disease Models, Animal; Gene Expression; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Gene Regulatory Networks; Glioblastoma; Glycoproteins; Humans; Neoplastic Stem Cells; Peptides; Prognosis; Pyrvinium Compounds; Signal Transduction; Spheroids, Cellular; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2015